NO961405L - Kondenserte heksacykliske forbindelser og fremgangsmåter for fremstilling derav - Google Patents

Kondenserte heksacykliske forbindelser og fremgangsmåter for fremstilling derav

Info

Publication number
NO961405L
NO961405L NO961405A NO961405A NO961405L NO 961405 L NO961405 L NO 961405L NO 961405 A NO961405 A NO 961405A NO 961405 A NO961405 A NO 961405A NO 961405 L NO961405 L NO 961405L
Authority
NO
Norway
Prior art keywords
preparation
compound
processes
hexacyclic compounds
formula
Prior art date
Application number
NO961405A
Other languages
English (en)
Other versions
NO314085B1 (no
NO961405D0 (no
Inventor
Shinji Kamihara
Kazuaki Kanai
Shigeru Noguchi
Hirofumi Terasawa
Hiroaki Kitaoka
Original Assignee
Daiichi Seiyaku Co
Yakult Honsha Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co, Yakult Honsha Kk filed Critical Daiichi Seiyaku Co
Publication of NO961405D0 publication Critical patent/NO961405D0/no
Publication of NO961405L publication Critical patent/NO961405L/no
Publication of NO314085B1 publication Critical patent/NO314085B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed systems contains four or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO19961405A 1995-04-10 1996-04-09 Kondenserte heksacykliske forbindelser og fremgangsmåter for fremstilling derav, samt farmasöytiske preparater inneholdende dem NO314085B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8371795 1995-04-10

Publications (3)

Publication Number Publication Date
NO961405D0 NO961405D0 (no) 1996-04-09
NO961405L true NO961405L (no) 1996-10-11
NO314085B1 NO314085B1 (no) 2003-01-27

Family

ID=13810270

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19961405A NO314085B1 (no) 1995-04-10 1996-04-09 Kondenserte heksacykliske forbindelser og fremgangsmåter for fremstilling derav, samt farmasöytiske preparater inneholdende dem

Country Status (13)

Country Link
US (2) US6504029B1 (no)
EP (1) EP0737686B1 (no)
KR (1) KR100400941B1 (no)
CN (1) CN1050131C (no)
AT (1) ATE181919T1 (no)
CA (1) CA2173671A1 (no)
DE (1) DE69603117T2 (no)
DK (1) DK0737686T3 (no)
EA (1) EA000036B1 (no)
ES (1) ES2136338T3 (no)
GR (1) GR3031400T3 (no)
NO (1) NO314085B1 (no)
TW (1) TW382630B (no)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60124387T2 (de) 2000-02-28 2007-10-11 Pfizer Enterprises Sarl. Synergistische pharmazeutische Zusammensetzungen zur Behandlung von kolorektalem Krebs
US6548488B2 (en) 2000-03-17 2003-04-15 Aventis Pharma S.A. Composition comprising camptothecin or a camptothecin derivative and an alkylating agent for the treatment of cancer
US6545010B2 (en) 2000-03-17 2003-04-08 Aventis Pharma S.A. Composition comprising camptothecin or a camptothecin derivative and a platin derivative for the treatment of cancer
AR030207A1 (es) * 2000-04-07 2003-08-13 Daiichi Seiyaku Co Composicion farmaceutica que contiene un derivado de camptotecina y procedimiento de preparacion de la misma
US6486320B2 (en) 2000-09-15 2002-11-26 Aventis Pharma S.A. Preparation of camptothecin and of its derivatives
SK5122003A3 (en) 2000-10-27 2003-12-02 Aventis Pharma Sa A combination comprising camptothecin and a stilbene derivative for the treatment of cancer
WO2006069344A2 (en) 2004-12-22 2006-06-29 Rutgers, The State University Of New Jersey Controlled release hydrogels
EP1998809B1 (en) 2006-03-30 2014-06-25 Drais Pharmaceuticals, Inc. Camptothecin-cell penetrating peptide conjugates and pharmaceutical compositions containing the same
US8173621B2 (en) 2008-06-11 2012-05-08 Gilead Pharmasset Llc Nucleoside cyclicphosphates
CL2009002206A1 (es) 2008-12-23 2011-08-26 Gilead Pharmasset Llc Compuestos derivados de pirrolo -(2-3-d]-pirimidin-7(6h)-tetrahidrofuran-2-il fosfonamidato, composicion farmaceutica; y su uso en el tratamiento de enfermedades virales.
MX2011006890A (es) 2008-12-23 2011-07-20 Pharmasset Inc Analogos de nucleosidos.
AR074897A1 (es) 2008-12-23 2011-02-23 Pharmasset Inc Fosforamidatos de nucleosidos
AP2012006535A0 (en) 2010-03-31 2012-10-31 Gilead Pharmasset Llc Stereoselective synthesis of phosphorous containing actives
US20140086975A1 (en) 2010-10-15 2014-03-27 Rutgers, The State University Of New Jersey Hydrogel formulation for dermal and ocular delivery
US10195288B2 (en) 2012-10-11 2019-02-05 Daiichi Sankyo Company, Limited Antibody-drug conjugate
EP2910573B1 (en) 2012-10-19 2020-02-19 Daiichi Sankyo Company, Limited Antibody-drug conjugate produced by binding through linker having hydrophilic structure
SG10201902571VA (en) 2013-12-25 2019-04-29 Daiichi Sankyo Co Ltd Anti-trop2 antibody-drug conjugate
SG11201603960XA (en) 2014-01-31 2016-07-28 Daiichi Sankyo Co Ltd Anti-her2 antibody-drug conjugate
TWI871999B (zh) 2014-04-10 2025-02-01 日商第一三共股份有限公司 抗her3抗體-藥物結合物
US11185594B2 (en) 2014-04-10 2021-11-30 Daiichi Sankyo Company, Limited (Anti-HER2 antibody)-drug conjugate
US12685781B2 (en) 2014-04-10 2026-07-21 Daiichi Sankyo Company, Limited Anti-HER3 antibody-drug conjugate
CA2990572C (en) 2015-06-29 2022-07-26 Daiichi Sankyo Company, Limited Method for selectively manufacturing antibody-drug conjugate
WO2018066626A1 (ja) 2016-10-07 2018-04-12 第一三共株式会社 抗ｈｅｒ２抗体－薬物コンジュゲート投与による耐性癌の治療
JPWO2018110515A1 (ja) 2016-12-12 2019-10-24 第一三共株式会社 抗体−薬物コンジュゲートと免疫チェックポイント阻害剤の組み合わせ
SG11201906554RA (en) 2017-01-17 2019-08-27 Daiichi Sankyo Co Ltd Anti-gpr20 antibody and anti-gpr20 antibody-drug conjugate
US12667557B2 (en) 2017-02-28 2026-06-30 Daiichi Sankyo Company, Limited Method for treating EGFR-TKI-resistant non-small cell lung cancer by administration of anti-HER3 antibody-drug conjugate
TWI926682B (zh) 2017-05-15 2026-05-21 日商第一三共股份有限公司 抗體－藥物結合物之製造方法
SG11202001514XA (en) * 2017-08-31 2020-03-30 Daiichi Sankyo Co Ltd Novel method for producing antibody-drug conjugate
EP3677589B1 (en) 2017-08-31 2025-11-26 Daiichi Sankyo Company, Limited Improved method for producing antibody-drug conjugate
EP3794042B1 (en) 2018-05-18 2024-03-27 Daiichi Sankyo Co., Ltd. Anti-muc1- exatecan antibody-drug conjugate
EP3831853A4 (en) 2018-07-27 2022-06-01 Daiichi Sankyo Company, Limited ANTIBODY-DRUG CONJUGATE PROTEIN-RECOGNIZING DRUG UNIT
IL325918A (en) 2018-07-31 2026-03-01 Daiichi Sankyo Co Ltd Antibody-drug conjugates for use in the treatment of metastatic brain tumor
UA130338C2 (uk) 2018-09-26 2026-01-28 Джянгсу Хенгруй Медісін Ко., Лтд. Кон'югат ліганд-лікарський засіб аналога ексатекану, спосіб його отримання та його застосування
JP7408646B2 (ja) 2018-09-30 2024-01-05 ジエンス ハンソー ファーマスーティカル グループ カンパニー リミテッド 抗－ｂ７ｈ３抗体－エキサテカンアナログコンジュゲート及びその医薬用途
KR20240104214A (ko) 2019-03-29 2024-07-04 메디뮨 리미티드 화합물 및 이의 접합체
BR112022000297A2 (pt) 2019-07-10 2022-03-15 Cybrexa 3 Inc Conjugados de peptídeos de agentes de alvo de microtúbulos como terapêuticos
MX2022000449A (es) 2019-07-10 2022-04-25 Cybrexa 2 Inc Conjugados peptídicos de citotoxinas como terapéuticos.
AU2020402006A1 (en) 2019-12-12 2022-07-07 Jiangsu Hengrui Medicine Co., Ltd. Anti-claudin antibody-drug conjugate and pharmaceutical use thereof
US20230101735A1 (en) 2020-01-22 2023-03-30 Jiangsu Hengrui Medicine Co., Ltd. Anti-trop-2 antidody-exatecan analog conjugate and medical use thereof
CN115103691B (zh) 2020-03-25 2025-01-24 苏州盛迪亚生物医药有限公司 一种含抗体药物偶联物的药物组合物及其用途
MX2022011808A (es) 2020-03-25 2022-12-06 Jiangsu Hengrui Pharmaceuticals Co Ltd Conjugado de anticuerpo anti-psma-analogo de exatecan y uso medico del mismo.
CA3175048A1 (en) 2020-03-25 2021-09-30 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Preparation method for antibody medicament conjugate
CN117940432B (zh) * 2021-09-01 2025-12-23 上海弼领生物技术有限公司 一种喜树碱类化合物、其制备方法和用途
CN117986268A (zh) * 2022-10-28 2024-05-07 安徽皓元药业有限公司 一种依喜替康甲磺酸盐的晶型及其制备方法
EP4650355A1 (en) * 2023-01-09 2025-11-19 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Preparation method for nitrogen-containing fused ring compound

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6087746A (ja) * 1983-10-17 1985-05-17 Hakubakumai Kk 即席麺ないしは焼そば用蒸し麺の製造方法
US4939255A (en) * 1987-06-24 1990-07-03 Daiichi Pharmaceutical Co., Ltd. Hexa-cyclic camptothecin derivatives
US4943579A (en) * 1987-10-06 1990-07-24 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Water soluble prodrugs of camptothecin
US5004758A (en) * 1987-12-01 1991-04-02 Smithkline Beecham Corporation Water soluble camptothecin analogs useful for inhibiting the growth of animal tumor cells
JP3008226B2 (ja) * 1991-01-16 2000-02-14 第一製薬株式会社 六環性化合物
US5658920A (en) * 1991-01-16 1997-08-19 Daiichi Pharmaceutical Co., Ltd. Substituted 1H,12H-benz-[DE]pyrano[3',4':6,7] indolizino[1,2-B]quinoline-10,13(9H,15H)-dione compound
JP3359955B2 (ja) * 1992-07-16 2002-12-24 第一製薬株式会社 抗腫瘍剤
IS4152A (is) * 1993-04-29 1994-10-30 Glaxo Inc. Vatnsuppleysanlegar Camptothecin afleiður og aðferð til framleiðslu þeirra
GB9319944D0 (en) * 1993-09-28 1993-11-17 Erba Carlo Spa Process for the preparation of 9-amino camptothecin

Also Published As

Publication number Publication date
NO314085B1 (no) 2003-01-27
KR100400941B1 (ko) 2003-12-24
KR960037682A (ko) 1996-11-19
US6504029B1 (en) 2003-01-07
DK0737686T3 (da) 1999-11-22
US6552197B2 (en) 2003-04-22
AU692078B2 (en) 1998-05-28
EP0737686B1 (en) 1999-07-07
ES2136338T3 (es) 1999-11-16
US20010034446A1 (en) 2001-10-25
EA199600018A3 (ru) 1997-03-31
ATE181919T1 (de) 1999-07-15
CN1133290A (zh) 1996-10-16
GR3031400T3 (en) 2000-01-31
DE69603117T2 (de) 1999-10-28
TW382630B (en) 2000-02-21
EA000036B1 (ru) 1998-02-26
DE69603117D1 (de) 1999-08-12
EP0737686A1 (en) 1996-10-16
CN1050131C (zh) 2000-03-08
CA2173671A1 (en) 1996-10-11
AU5056696A (en) 1996-10-24
EA199600018A2 (ru) 1996-10-01
NO961405D0 (no) 1996-04-09

Similar Documents

Publication Publication Date Title
NO961405D0 (no) Kondenserte heksacykliske forbindelser og fremgangsmåter for fremstilling derav
Gibson et al. Selective removal of an N-BOC protecting group in the presence of a tert-butyl ester and other acid-sensitive groups
ES8106721A1 (es) Un metodo para la preparacion de derivados de ftalimidina
ATE188707T1 (de) Verfahren zur herstellung von alanylglutamin
FR2598146B1 (fr) Nouveau procede de preparation de fibrates.
NO882588L (no) Fremgangsmaate ved fremstilling av substituerte inololinonderivater.
ATE150463T1 (de) Verfahren zur herstellung von antimikrobiellen quinolonyl-lactamen
HUT37141A (en) Process for production of substituted 5,11-dihydro-6h-dibenz /b,e/ azepin-6-ons
BR0213814A (pt) Processos para a fabricação de 3-hidroxi-n, 1,6-trialquil-4-oxo-1, 4-diidro piridino-2-carboxamida
KR880700793A (ko) 퀴놀린 카복실산의 제조 방법
KR910002865A (ko) 피라노벤즈옥사디아졸 화합물 및 그 광학적 분할방법
ES2053707T3 (es) Procedimiento para la preparacion de amidas de acidos 3,3-diaril-acrilicos.
KR910002784A (ko) 비대칭적으로 치환된 우레아의 제조방법
SE8503811D0 (sv) Novel process for the preparation of an aminolactone
DE59406746D1 (de) Verfahren zur herstellung von schwefelsäurehalbestern
FR2453864A1 (fr) Procede de fabrication de derives de l'acide 6-b-amidinopenicillanique
DK159432C (da) Fremgangsmaade til fremstilling af 4-amino-5-dialkoxymethylpyrimidinderivater
ATE159519T1 (de) Verfahren zur herstellung von n-phenyl-n-(4- piperidinyl)amid-derivaten
ES497136A0 (es) Procedimiento para la sintesis de esteres de la n-(4'hidro- xifenil) acetamida con acidos 5-benzoil-1-metilpirrol-2-ace-tico
Bogdanowicz-Szwed et al. Synthesis of pyridine derivatives by reactions of α, β-unsaturated nitriles with 2-oxo-cycloalkano carbothioic acid anilides
SU660970A1 (ru) Способ получени 1-адамантилмалоновой кислоты